Distinct parameters of the basophil activation test reflect the severity and threshold of allergic reactions to peanut

Journal of Allergy and Clinical Immunology

Volumn 135, Issue 1, 2015, Pages 179-186

  Santos, Alexandra F ^a,b,c,d   Du Toit, George ^a,b   Douiri, Abdel ^e,f   Radulovic, Suzana ^a,b   Stephens, Alick ^a,b   Turcanu, Victor ^a,b   Lack, Gideon ^a,b  

^a Department of Pediatric Allergy St thomas'Hospital ^*  (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^d Gulbenkian Programme for Advanced Medical Education   (Portugal)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Basophil activation test; CD sens; CD203c; CD63; doubleblind; peanut, peanut allergy; placebo controlled food challenge; sensitivity; severity; threshold

Indexed keywords

CD63 ANTIGEN; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G4; CD63 PROTEIN, HUMAN; IMMUNOGLOBULIN E;

ADOLESCENT; ALLERGIC REACTION; ANAPHYLAXIS; AREA UNDER THE CURVE; ARTICLE; BASOPHIL ACTIVATION TEST; BASOPHIL DEGRANULATION; CHILD; DISEASE SEVERITY; EC50; FEMALE; HUMAN; IMMUNE FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PEANUT ALLERGY; PRICK TEST; RECEIVER OPERATING CHARACTERISTIC; SKIN TEST; ADVERSE EFFECTS; ARACHIS; BASOPHIL; BLOOD; CLINICAL TRIAL; IMMUNOLOGICAL PROCEDURES; IMMUNOLOGY; INFANT; PEANUT HYPERSENSITIVITY; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; ANTIGENS, CD63; ARACHIS; BASOPHILS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULIN E; IMMUNOLOGIC TESTS; INFANT; MALE; PEANUT HYPERSENSITIVITY; SEVERITY OF ILLNESS INDEX;

EID: 84920379596     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2014.09.001     Document Type: Article

References (43)

1. S.H. Sicherer, A. Munoz-Furlong, J.H. Godbold, and H.A. Sampson US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up J Allergy Clin Immunol 125 2010 1322 1326
2. G. Du Toit, Y. Katz, P. Sasieni, D. Mesher, S.J. Maleki, and H.R. Fisher Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy J Allergy Clin Immunol 122 2008 984 991
3. R.Y. Lin, A.S. Anderson, S.N. Shah, and F. Nurruzzaman Increasing anaphylaxis hospitalizations in the first 2 decades of life: New York State, 1990-2006 Ann Allergy Asthma Immunol 101 2008 387 393
4. C.W. Summers, R.S. Pumphrey, C.N. Woods, G. McDowell, P.W. Pemberton, and P.D. Arkwright Factors predicting anaphylaxis to peanuts and tree nuts in patients referred to a specialist center J Allergy Clin Immunol 121 2008 632 638.e2
5. T.T. Perry, E.C. Matsui, M.K. Conover-Walker, and R.A. Wood Risk of oral food challenges J Allergy Clin Immunol 114 2004 1164 1168
6. D.L. Neuman-Sunshine, J.A. Eckman, C.A. Keet, E.C. Matsui, R.D. Peng, and P.J. Lenehan The natural history of persistent peanut allergy Ann Allergy Asthma Immunol 108 2012 326 331.e3
7. A. Muraro, G. Roberts, M. Worm, M.B. Bilo, K. Brockow, and M. Fernandez Rivas Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology Allergy 69 2014 1026 1045
8. P. Lieberman, R.A. Nicklas, J. Oppenheimer, S.F. Kemp, D.M. Lang, and D.I. Bernstein The diagnosis and management of anaphylaxis practice parameter: 2010 update J Allergy Clin Immunol 126 2010 477 480 e1-42
9. F.E. Simons, L.R. Ardusso, M.B. Bilo, Y.M. El-Gamal, D.K. Ledford, and J. Ring World Allergy Organization anaphylaxis guidelines: summary J Allergy Clin Immunol 127 2011 587 593 e1-22
10. R.S. Pumphrey Lessons for management of anaphylaxis from a study of fatal reactions Clin Exp Allergy 30 2000 1144 1150
11. R.S. Pumphrey, and M.H. Gowland Further fatal allergic reactions to food in the United Kingdom, 1999-2006 J Allergy Clin Immunol 119 2007 1018 1019
12. K. Blumchen, A. Beder, J. Beschorner, F. Ahrens, A. Gruebl, and E. Hamelmann Modified oral food challenge used with sensitization biomarkers provides more real-life clinical thresholds for peanut allergy J Allergy Clin Immunol 134 2014 390 398.e4
13. C. Bindslev-Jensen, B.K. Ballmer-Weber, U. Bengtsson, C. Blanco, C. Ebner, and J. Hourihane Standardization of food challenges in patients with immediate reactions to foods - position paper from the European Academy of Allergology and Clinical Immunology Allergy 59 2004 690 697
14. A.F. Santos, A. Douiri, N. Bécares, S.Y. Wu, A. Stephens, and S. Radulovic Basophil activation test discriminates between allergy and tolerance in peanut-sensitized children J Allergy Clin Immunol 134 2014 645 652
15. S.U. Patil, and W.G. Shreffler Immunology in the Clinic Review Series; focus on allergies: basophils as biomarkers for assessing immune modulation Clin Exp Immunol 167 2012 59 66
16. G. Du Toit, G. Roberts, P.H. Sayre, M. Plaut, H.T. Bahnson, and H. Mitchell Identifying infants at high risk of peanut allergy: the Learning Early About Peanut Allergy (LEAP) screening study J Allergy Clin Immunol 131 2013 135 143 e1-12
17. T. Marrs, G. Du Toit, A.T. Fox, M. Perkin, and G. Lack Double-blind food challenges can be conducted effectively by using interspersed active and placebo doses among children J Allergy Clin Immunol 132 2013 502
18. P.W. Ewan, and A.T. Clark Long-term prospective observational study of patients with peanut and nut allergy after participation in a management plan Lancet 357 2001 111 115
19. H.L. Mueller Diagnosis and treatment of insect sensitivity J Asthma Res 3 1966 331 333
20. S.G. Brown Clinical features and severity grading of anaphylaxis J Allergy Clin Immunol 114 2004 371 376
21. H.A. Sampson Anaphylaxis and emergency treatment Pediatrics 111 2003 1601 1608
22. T. van der Zee, A. Dubois, M. Kerkhof, S. van der Heide, and B. Vlieg-Boerstra The eliciting dose of peanut in double-blind, placebo-controlled food challenges decreases with increasing age and specific IgE level in children and young adults J Allergy Clin Immunol 128 2011 1031 1036
23. S.L. Taylor, S.L. Hefle, C. Bindslev-Jensen, F.M. Atkins, C. Andre, and C. Bruijnzeel-Koomen A consensus protocol for the determination of the threshold doses for allergenic foods: how much is too much? Clin Exp Allergy 34 2004 689 695
24. S.G. Johansson, A. Nopp, M. van Hage, N. Olofsson, J. Lundahl, and L. Wehlin Passive IgE-sensitization by blood transfusion Allergy 60 2005 1192 1199
25. V. Ta, B. Weldon, G. Yu, O. Humblet, S. Neale-May, and K. Nadeau Use of specific IgE and skin prick test to determine clinical reaction severity Br J Med Med Res 1 2011 410 429
26. C. Astier, M. Morisset, O. Roitel, F. Codreanu, S. Jacquenet, and P. Franck Predictive value of skin prick tests using recombinant allergens for diagnosis of peanut allergy J Allergy Clin Immunol 118 2006 250 256
27. W.G. Shreffler Evaluation of basophil activation in food allergy: present and future applications Curr Opin Allergy Clin Immunol 6 2006 226 233
28. A. Rubio, M. Vivinus-Nebot, T. Bourrier, B. Saggio, M. Albertini, and A. Bernard Benefit of the basophil activation test in deciding when to reintroduce cow's milk in allergic children Allergy 66 2011 92 100
29. H.A. Sampson, R. Gerth van Wijk, C. Bindslev-Jensen, S. Sicherer, S.S. Teuber, and A.W. Burks Standardizing double-blind, placebo-controlled oral food challenges: American Academy of Allergy, Asthma & Immunology-European Academy of Allergy and Clinical Immunology PRACTALL consensus report J Allergy Clin Immunol 130 2012 1260 1274
30. LEAP: learning early about peanut allergy. Available at: www.leapstudy.co.uk. Accessed August 12, 2014.
31. B.K. Wainstein, J. Studdert, M. Ziegler, and J.B. Ziegler Prediction of anaphylaxis during peanut food challenge: usefulness of the peanut skin prick test (SPT) and specific IgE level Pediatr Allergy Immunol 21 2010 603 611
32. A.E. Flinterman, S.G. Pasmans, M.O. Hoekstra, Y. Meijer, E. van Hoffen, and E.F. Knol Determination of no-observed-adverse-effect levels and eliciting doses in a representative group of peanut-sensitized children J Allergy Clin Immunol 117 2006 448 454
33. J.O. Hourihane, K.E. Grimshaw, S.A. Lewis, R.A. Briggs, J.B. Trewin, and R.M. King Does severity of low-dose, double-blind, placebo-controlled food challenges reflect severity of allergic reactions to peanut in the community? Clin Exp Allergy 35 2005 1227 1233
34. S.A. Lewis, K.E. Grimshaw, J.O. Warner, and J.O. Hourihane The promiscuity of immunoglobulin E binding to peanut allergens, as determined by Western blotting, correlates with the severity of clinical symptoms Clin Exp Allergy 35 2005 767 773
35. K.A. Peeters, S.J. Koppelman, E. van Hoffen, C.W. van der Tas, C.F. den Hartog Jager, and A.H. Penninks Does skin prick test reactivity to purified allergens correlate with clinical severity of peanut allergy? Clin Exp Allergy 37 2007 108 115
36. A.E. Flinterman, E.F. Knol, D.A. Lencer, L. Bardina, C.F. den Hartog Jager, and J. Lin Peanut epitopes for IgE and IgG4 in peanut-sensitized children in relation to severity of peanut allergy J Allergy Clin Immunol 121 2008 737 743.e10
37. M. Wensing, A.H. Penninks, S.L. Hefle, S.J. Koppelman, C.A. Bruijnzeel-Koomen, and A.C. Knulst The distribution of individual threshold doses eliciting allergic reactions in a population with peanut allergy J Allergy Clin Immunol 110 2002 915 920
38. E. Eller, and C. Bindslev-Jensen Clinical value of component-resolved diagnostics in peanut-allergic patients Allergy 68 2013 190 194
39. K. Mudd, M. Paterakis, J. Curtin-Brosnan, E. Matsui, and R. Wood Predicting outcome of repeat milk, egg, or peanut oral food challenges J Allergy Clin Immunol 124 2009 1115 1116
40. S. Glaumann, A. Nopp, S.G. Johansson, M.P. Borres, and C. Nilsson Oral peanut challenge identifies an allergy but the peanut allergen threshold sensitivity is not reproducible PLoS One 8 2013 e53465
41. S.M. Jones, L. Pons, J.L. Roberts, A.M. Scurlock, T.T. Perry, and M. Kulis Clinical efficacy and immune regulation with peanut oral immunotherapy J Allergy Clin Immunol 124 2009 292 300 e1-97
42. A.W. Burks, S.M. Jones, R.A. Wood, D.M. Fleischer, S.H. Sicherer, and R.W. Lindblad Oral immunotherapy for treatment of egg allergy in children N Engl J Med 367 2012 233 243
43. C.A. Keet, P.A. Frischmeyer-Guerrerio, A. Thyagarajan, J.T. Schroeder, R.G. Hamilton, and S. Boden The safety and efficacy of sublingual and oral immunotherapy for milk allergy J Allergy Clin Immunol 129 2012 448 455 e1-5